Effect of Ascites Replacement Strategy on Time to 1st Flatus After LDLT

• Status: Recruiting
• Trial end date: 2021-10-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to evaluate difference in the rate of recovery of intestinal motility according to different ascites replacement strategy after living donor liver transplantation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Collaborator: GC Pharma
• Treatments: Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Adults (19 years or older)

• Elective living donor liver transplantation

Exclusion Criteria:

• Previous abdominal surgery

• Renal failure requiring renal replacement therapy

• Contraindications for 5% albumin use

1. Condition with potential risk caused by increased circulating plasma (heart failure, renal failure combined with oliguria, pulmonary edema)

2. Hemolytic anemia

• Contraindications for Hartmann solution

1. Progressive lactic acidosis

2. Hypervolemia

3. Hypernatremia